References
- Public health (ARTAS, CTR & CRCS), behavioral. overview of select interventions & strategies: biomedical (medication adherence). Available from: https://effectiveinterventions.cdc.gov/docs/default-source/general-docs/14-1021-hip-overview-factsheet.pdf?sfvrsn=0 (Accessed 2015 September 21).
- Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris Ret al., Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med. 2009;361:2209–2220.
- Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LEet al., Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329:1168–1174.
- Ferrer RA, Morrow KM, Fisher WA, Fisher JD. Toward an information-motivation-behavioral skills model of microbicide adherence in clinical trials. AIDS Care. 2010;22(8):997–1005.
- O'Hagan JJ, Hernan MA, Walensky RP, Lipstitch M. Apparent declining efficacy in randomized trials: examples of the Thai RV144 HIV vaccine and South African CAPRISA 004 microbicide trials. AIDS. 2012;26:123–126.
- Grobler A, Karim SAet al., Declining adherence as a more likely explanation than frailty of the apparent decline in efficacy in the CAPRISA 004 trial: response to O'Hagan et al.. AIDS. 2012;26:2261–2265.
- Dai JY, Gilbert PB, Hughes JP, Brown ER. Estimating the efficacy of preexposure prophylaxis for HIV prevention among participants with a threshold level of drug concentration. Am J Epidemiol. 2013;177(3):256–263.